Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1980 2
1984 2
1986 1
1987 2
1988 2
1989 1
1991 1
1993 1
1995 5
1997 1
1998 2
1999 3
2000 3
2001 2
2002 6
2003 4
2004 2
2005 1
2006 3
2007 6
2008 7
2009 7
2010 7
2011 7
2012 2
2013 3
2014 7
2015 16
2016 13
2017 12
2018 9
2019 11
2020 19
2021 31
2022 26
2023 25
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and Management of Pituitary Adenomas: A Review.
Tritos NA, Miller KK. Tritos NA, et al. JAMA. 2023 Apr 25;329(16):1386-1398. doi: 10.1001/jama.2023.5444. JAMA. 2023. PMID: 37097352 Review.
Macroadenomas may cause mass effect, such as visual field defects, headache, and/or hypopituitarism, which occur in about 18% to 78%, 17% to 75%, and 34% to 89% of patients, respectively. ...Patients with macroadenomas additionally require evaluation for hypopituitarism, a …
Macroadenomas may cause mass effect, such as visual field defects, headache, and/or hypopituitarism, which occur in about 18% to 78%, …
Parkinson's disease: etiopathogenesis and treatment.
Jankovic J, Tan EK. Jankovic J, et al. J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):795-808. doi: 10.1136/jnnp-2019-322338. Epub 2020 Jun 23. J Neurol Neurosurg Psychiatry. 2020. PMID: 32576618 Review.
The involvement of dopaminergic as well as noradrenergic, glutamatergic, serotonergic and adenosine pathways provide insights into the rich and variable clinical phenomenology associated with PD and the possibility of alternative therapeutic approaches beyond traditional d …
The involvement of dopaminergic as well as noradrenergic, glutamatergic, serotonergic and adenosine pathways provide insights into the rich …
Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.
Stamou MI, Georgopoulos NA. Stamou MI, et al. Metabolism. 2018 Sep;86:124-134. doi: 10.1016/j.metabol.2017.10.012. Epub 2017 Nov 3. Metabolism. 2018. PMID: 29108899 Free PMC article. Review.
The clinical spectrum of IGD includes a variety of disorders including Kallmann Syndrome (KS), i.e. hypogonadotropic hypogonadism with anosmia, and its normosmic variation normosmic idiopathic hypogonadotropic hypogonadism (nIHH), which represen …
The clinical spectrum of IGD includes a variety of disorders including Kallmann Syndrome (KS), i.e. hypogonadotropic hypogonadism
Investigation and management of subfertility.
Thurston L, Abbara A, Dhillo WS. Thurston L, et al. J Clin Pathol. 2019 Sep;72(9):579-587. doi: 10.1136/jclinpath-2018-205579. Epub 2019 Jul 11. J Clin Pathol. 2019. PMID: 31296604 Free article. Review.
Ovulation can be restored in women with PCOS using letrozole (an aromatase inhibitor), clomifene citrate (an oestrogen antagonist) or exogenous gonadotrophin administration. If available, pulsatile gonadotrophin releasing hormone therapy is the preferred option for restori …
Ovulation can be restored in women with PCOS using letrozole (an aromatase inhibitor), clomifene citrate (an oestrogen antagonist) or exogen …
Headache associated with COVID-19: Epidemiology, characteristics, pathophysiology, and management.
Sampaio Rocha-Filho PA. Sampaio Rocha-Filho PA. Headache. 2022 Jun;62(6):650-656. doi: 10.1111/head.14319. Epub 2022 May 11. Headache. 2022. PMID: 35545780 Free PMC article. Review.
BACKGROUND: Headache is a frequent symptom of COVID-19, and understanding its management is important for health-care professionals involved in treating the disease. METHOD: This is a narrative review. ...RESULTS: Half of the patients who have COVID-19 present with headach …
BACKGROUND: Headache is a frequent symptom of COVID-19, and understanding its management is important for health-care professionals i …
Current clinical management of constitutional delay of growth and puberty.
Gaudino R, De Filippo G, Bozzola E, Gasparri M, Bozzola M, Villani A, Radetti G. Gaudino R, et al. Ital J Pediatr. 2022 Mar 24;48(1):45. doi: 10.1186/s13052-022-01242-5. Ital J Pediatr. 2022. PMID: 35331309 Free PMC article. Review.
In details, pediatricians often cannot differentiate CDGP from permanent hypogonadotropic hypogonadism (PHH), with definitive diagnosis of PHH awaiting lack of puberty by age 18 yr. ...Patients with transient delay in hypothalamic-pituitary-gonadal axis matur …
In details, pediatricians often cannot differentiate CDGP from permanent hypogonadotropic hypogonadism (PHH), with definitive …
Post-COVID-19 acute sarcopenia: physiopathology and management.
Piotrowicz K, Gąsowski J, Michel JP, Veronese N. Piotrowicz K, et al. Aging Clin Exp Res. 2021 Oct;33(10):2887-2898. doi: 10.1007/s40520-021-01942-8. Epub 2021 Jul 30. Aging Clin Exp Res. 2021. PMID: 34328636 Free PMC article. Review.
The aftermath of these acute and complex immunological SARS-CoV-2-related phenomena, augmented by anosmia, ageusia and altered microbiota may lead to decreased food intake and exacerbated catabolism. ...
The aftermath of these acute and complex immunological SARS-CoV-2-related phenomena, augmented by anosmia, ageusia and altered microb …
Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment.
Boehm U, Bouloux PM, Dattani MT, de Roux N, Dodé C, Dunkel L, Dwyer AA, Giacobini P, Hardelin JP, Juul A, Maghnie M, Pitteloud N, Prevot V, Raivio T, Tena-Sempere M, Quinton R, Young J. Boehm U, et al. Nat Rev Endocrinol. 2015 Sep;11(9):547-64. doi: 10.1038/nrendo.2015.112. Epub 2015 Jul 21. Nat Rev Endocrinol. 2015. PMID: 26194704 Review.
Congenital hypogonadotropic hypogonadism (CHH) is a rare disorder caused by the deficient production, secretion or action of gonadotropin-releasing hormone (GnRH), which is the master hormone regulating the reproductive axis. ...Clinically, the disorder is character …
Congenital hypogonadotropic hypogonadism (CHH) is a rare disorder caused by the deficient production, secretion or action of g …
Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.
Anon JB, Jacobs MR, Poole MD, Ambrose PG, Benninger MS, Hadley JA, Craig WA; Sinus And Allergy Health Partnership. Anon JB, et al. Otolaryngol Head Neck Surg. 2004 Jan;130(1 Suppl):1-45. doi: 10.1016/j.otohns.2003.12.003. Otolaryngol Head Neck Surg. 2004. PMID: 14726904 Free PMC article. Review.
Rifampin is also a well-known inducer of several cytochrome p450 isoenzymes and therefore has a high potential for drug interactions. Failure of a patient to respond to antimicrobial therapy after 72 hours of therapy should prompt either a switch to alternate antimi …
Rifampin is also a well-known inducer of several cytochrome p450 isoenzymes and therefore has a high potential for drug interactions. Failur …
Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment.
Clasen SC, Fung C, Sesso HD, Travis LB. Clasen SC, et al. Curr Oncol Rep. 2023 May;25(5):445-454. doi: 10.1007/s11912-023-01375-8. Epub 2023 Mar 3. Curr Oncol Rep. 2023. PMID: 36867377 Review.
PURPOSE OF REVIEW: Testicular cancer (TC) is the leading cancer in men between 18 and 39 years of age. Current treatment involves tumor resection followed by surveillance and/or one or more lines of cisplatin-based chemotherapy (CBCT) and/or bone marrow transplant (BMT). . …
PURPOSE OF REVIEW: Testicular cancer (TC) is the leading cancer in men between 18 and 39 years of age. Current treatment involves tum …
225 results